Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Unresectable Mesothelioma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT04272034
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsMSI-H/dMMR TumorsCutaneous Squamous Cell Carcinoma+15 more
Incyte Corporation 105
Early research (Phase 1)WithdrawnNCT02639767
What this trial is testing

Concurrent Pemetrexed/Cisplatin With Pleural Intensity Modulated Radiation Therapy for Patients With Unresectable Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT06535607
What this trial is testing

Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors

Who this might be right for
Sub-study 1 Cervical Cancer (Volrustomig Monotherapy)Sub-study 2 Head and Neck Squamous Cell Carcinoma (Volrustomig Monotherapy)Sub-study 3 Head and Neck Squamous Cell Carcinoma (Volrustomig in Combination With Chemotherapy)+2 more
AstraZeneca
Large-scale testing (Phase 3)Study completedNCT04334759
What this trial is testing

DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma

Who this might be right for
MesotheliomaPleural MesotheliomaMalignant Pleural Mesothelioma
PrECOG, LLC. 214
Not applicableStudy completedNCT05308966
What this trial is testing

Observational Study in Patients With Previously Unresectable Malignant Pleural Mesothelioma Treated With Nivolumab and Ipilimumab (MESO-IMMUNE)

Who this might be right for
Malignant Pleural MesotheliomaUnresectable Malignant Neoplasm
Groupe Francais De Pneumo-Cancerologie 204
Large-scale testing (Phase 3)Study completedNCT02899299
What this trial is testing

Study of Nivolumab Combined With Ipilimumab Versus Pemetrexed and Cisplatin or Carboplatin as First Line Therapy in Unresectable Pleural Mesothelioma Patients

Who this might be right for
Mesothelioma
Bristol-Myers Squibb 605
Testing effectiveness (Phase 2)Study completedNCT05136677
What this trial is testing

Evaluate Nivolumab in Combination With Ipilimumab Versus Pemetrexed With Cisplatin or Carboplatin for Unresectable Pleural Mesothelioma in Chinese Participants

Who this might be right for
Mesothelioma, Malignant
Bristol-Myers Squibb 102
Early research (Phase 1)Ended earlyNCT01445392
What this trial is testing

SS1(dsFV)PE38 Plus Pemetrexed and Cisplatin to Treat Malignant Pleural Mesothelioma

Who this might be right for
Mesothelioma
National Cancer Institute (NCI) 24
Large-scale testing (Phase 3)Ended earlyNCT01907100
What this trial is testing

Nintedanib (BIBF 1120) in Mesothelioma

Who this might be right for
Mesothelioma
Boehringer Ingelheim 545
Early research (Phase 1)Study completedNCT00402766
What this trial is testing

Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma

Who this might be right for
Mesothelioma
M.D. Anderson Cancer Center 19
Testing effectiveness (Phase 2)UnknownNCT01655888
What this trial is testing

The Anti-CTLA-4 Monoclonal Antibody Tremelimumab in Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
Azienda Ospedaliera Universitaria Senese 29
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Looking for participantsNCT07510815
What this trial is testing

Dual-Target MSLN/FAP CAR-NK Cells for Pleural and Peritoneal Mesothelioma

Who this might be right for
Malignant Pleural Mesotheliomas
Beijing Biotech 36
Testing effectiveness (Phase 2)Study completedNCT02899195
What this trial is testing

Phase II MEDI4736 in Combination With Chemotherapy for First-Line Treatment of Unresectable Mesothelioma

Who this might be right for
MesotheliomaPleural Mesothelioma
PrECOG, LLC. 55
Testing effectiveness (Phase 2)UnknownNCT02588131
What this trial is testing

Tremelimumab Combined With the Anti-PD-L1 MEDI4736 Antibody in Malignant Mesothelioma (NIBIT-MESO-1)

Who this might be right for
Pleural MesotheliomaPeritoneal Mesothelioma
Italian Network for Tumor Biotherapy Foundation 40
Early research (Phase 1)Study completedNCT00629343
What this trial is testing

Phase I Dose-Escalation Study Of Azacitidine In Combination With Temozolomide

Who this might be right for
Soft Tissue SarcomaMesothelioma
Columbia University 27
Early research (Phase 1)WithdrawnNCT02661659
What this trial is testing

A Phase Ib Trial of a Maintenance Multipeptide Vaccine (S-588210) in Patients With Unresectable Malignant Pleural Mesothelioma Without Progression After First-Line Chemotherapy

Who this might be right for
Malignant Pleural Mesothelioma (MPM)
University of Chicago
Testing effectiveness (Phase 2)UnknownNCT02879669
What this trial is testing

A Randomised Phase II Open-label Study With a Phase Ib Safety lead-in Cohort of ONCOS-102, an Immune-priming GM-CSF Coding Oncolytic Adenovirus, and Pemetrexed/Cisplatin in Patients With Unresectable Malignant Pleural Mesothelioma

Who this might be right for
To Determine Safety, Tolerability and Efficacy of ONCOS-102 in Combination With Chemotherapy
Targovax Oy 31
Testing effectiveness (Phase 2)Study completedNCT00053885
What this trial is testing

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
Alliance for Clinical Trials in Oncology 47
Testing effectiveness (Phase 2)Study completedNCT00003723
What this trial is testing

S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery

Who this might be right for
Malignant Mesothelioma
SWOG Cancer Research Network 57
Next Page
257